Nattokinase
Also called: natto extract
An enzyme secreted by the bacterium Bacillus subtilis when it ferments soybeans into natto, a food eaten in Japan for several centuries. In laboratory studies it breaks down fibrin, the protein that forms blood clots.
- Category
- Other
- Forms
- Nattokinase enzyme; trial doses stated in fibrinolytic units (FU)
- Strongest evidence
- B Some positive trials
- Reviewed
- 2026-10-30
Class 1 Well studied in people. A 2023 systematic review and meta-analysis of randomized controlled trials included six studies (546 participants) of nattokinase supplementation and cardiovascular risk factors. [2]
Fact-checked 2026-10-30 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BHeart and blood vessels3 topics
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Blood pressure in prehypertension or stage 1 hypertension | B | An 8-week RCT (86 adults, 2,000 FU/day; 73 completed) lowered systolic blood pressure by 5.55 mmHg and diastolic by 2.84 mmHg versus placebo; a 2023 meta-analysis of six RCTs also reported lower blood pressure. [3] |
| Progression of subclinical atherosclerosis | X | A double-blind RCT (NAPS; 265 adults without cardiovascular disease, 2,000 FU/day, median 3 years) found no effect on carotid intima-media thickness or arterial stiffness progression, blood pressure or any laboratory measure. [4] |
| Blood lipids | C | A 2023 meta-analysis (6 RCTs, 546 participants) found no lipid-lowering effect; with lower total doses, total and LDL cholesterol were higher and HDL cholesterol lower than with control, higher doses also had higher total cholesterol, blood glucose rose slightly, and triglycerides did not differ. [2] |
Main constituents: Nattokinase, an extracellular enzyme of Bacillus subtilis [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- 2,000 FU/day for 8 weeks (blood pressure trial). [3]
- 2,000 FU/day for a median of 3 years (NAPS). [4]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicines3 listed
Anticoagulant, antiplatelet and fibrinolytic drugs; Aspirin; Warfarin (natto food)
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications2 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- MSK: nattokinase may increase the risk of bleeding when used with blood-thinning drugs. Case reports include fatal internal bleeding in an elderly woman taking over-the-counter nattokinase for atrial fibrillation who was not taking other anticoagulants. [1]
- MSK case report: shortness of breath, mild chest pain and a thrombus on a mechanical heart valve, requiring repeat valve replacement, after long-term self-substitution of nattokinase for warfarin. [1]
- MSK: theoretically nattokinase can cause an existing clot to dislodge, resulting in stroke or embolus; people with a history of deep vein thrombosis should avoid it. [1]
- MSK case reports: anaphylaxis in a patient with fermented soybean allergy who ate natto, and urticaria due to natto (fermented soybeans). [1]
- The 2023 meta-analysis reported no notable adverse events due to nattokinase in the six included trials. [2]
Interactions
| With | What happens |
|---|---|
| Anticoagulant, antiplatelet and fibrinolytic drugs | MSK: people taking anticoagulant, fibrinolytic or antithrombotic treatments, and those with coagulation disorders, should avoid nattokinase; theoretically it may increase the risk of bleeding. [1] |
| Aspirin | MSK: nattokinase may increase the risk of intracerebral hemorrhage with aspirin. [1] |
| Warfarin (natto food) | MSK: raw natto contains high levels of vitamin K that may interfere with the action of warfarin. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Regulatory status
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-30). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Nattokinase Enzyme with fibrinolytic activity, secreted by Bacillus subtilis [P5]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 2 entries naming nattokinase (earliest NDI 149 submitted 2002-03-28, a nattokinase-containing substance; most recent NDI 631 submitted 2010-01-15). Each notification covers one firm's specific ingredient and conditions of use; the list does not state FDA's response. [P1]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- Anticoagulant, antiplatelet and fibrinolytic drugs: MSK: people taking anticoagulant, fibrinolytic or antithrombotic treatments, and those with coagulation disorders, should avoid nattokinase; theoretically it may increase the risk of bleeding. [P5]
- Aspirin: MSK: nattokinase may increase the risk of intracerebral hemorrhage with aspirin. [P5]
- Warfarin (natto food): MSK: raw natto contains high levels of vitamin K that may interfere with the action of warfarin. [P5]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P4]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (last update 2026-07-23; checked 2026-10-30), 2026-07-23. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606; checked 2026-10-30), 2026-10-30. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (current text, retrieved 2026-10-30), 2026-10-30. ecfr.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Nattokinase (last updated Thursday, April 14, 2022), 2022-04-14. mskcc.org
Sources
- Memorial Sloan Kettering Cancer Center. About Herbs: Nattokinase (last updated Thursday, April 14, 2022), 2022-04-14. mskcc.org
- Li X, et al. Nattokinase supplementation and cardiovascular risk factors: a systematic review and meta-analysis of randomized controlled trials. Rev Cardiovasc Med 2023;24(8):234 (PMID 39076715), 2023-08-15. pubmed.ncbi.nlm.nih.gov
- Kim JY, et al. Effects of nattokinase on blood pressure: a randomized, controlled trial. Hypertens Res 2008;31(8):1583-8 (PMID 18971533), 2008-08. pubmed.ncbi.nlm.nih.gov
- Hodis HN, et al. Nattokinase atherothrombotic prevention study: a randomized controlled trial. Clin Hemorheol Microcirc 2021;78(4):339-353 (PMID 33843667), 2021. pubmed.ncbi.nlm.nih.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (Content current as of 08/27/2026), 2026-08-27. fda.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in this category: Alpha-lipoic acid · Bee pollen · Beetroot juice (dietary nitrate) · Berberine · Beta-glucan (oat and barley) · Betaine (trimethylglycine) · Bromelain · Caffeine · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.